Koei Chemical Company, Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Koei Chemical Company, Limited with three other
companies in this sector in Japan:
Biofermin Pharmaceutical Company Limited
sales of 10.62 billion Japanese Yen [US$94.40 million]
of which 62%
was New BioferminS),
Wakamoto Pharmaceutical Co., Ltd.
(10.83 billion Japanese Yen [US$96.28 million]
of which 52%
was Medical Pharmaceutical Products), and
(29.59 billion Japanese Yen [US$263.05 million]
of which 82%
was Pharmaceutical Products).
Koei Chemical Company, Limited reported sales of ¥17.28 billion (US$153.61 million)
March of 2017.
decrease of 5.5%
versus 2016, when the company's sales were ¥18.28 billion.